Amgen Inc. (AMGN) - NASDAQ
  • Fri, Jul. 22, 4:06 PM
    • Amgen (NASDAQ:AMGN) declares $1.00/share quarterly dividend, in line with previous.
    • Forward yield 2.41%
    • Payable Sept. 8; for shareholders of record Aug. 17; ex-div Aug. 15.
    | Fri, Jul. 22, 4:06 PM | 3 Comments
  • Wed, Mar. 2, 4:23 PM
    | Wed, Mar. 2, 4:23 PM | 7 Comments
  • Dec. 15, 2015, 4:13 PM
    • Amgen (NASDAQ:AMGN) declares $1.00/share quarterly dividend, 26.6% increase from prior dividend of $0.79.
    • Forward yield 2.46%
    • Payable March 8; for shareholders of record Feb. 16; ex-div Feb. 11.
    | Dec. 15, 2015, 4:13 PM | 10 Comments
  • Oct. 14, 2015, 4:19 PM
    • Amgen (NASDAQ:AMGN) declares $0.79/share quarterly dividend, in line with previous.
    • Forward yield 2.14%
    • Payable Dec. 7; for shareholders of record Nov. 16; ex-div Nov. 12.
    | Oct. 14, 2015, 4:19 PM | 4 Comments
  • Jul. 28, 2015, 5:47 PM
    • Amgen (NASDAQ:AMGN) declares $0.79/share quarterly dividend, in line with previous.
    • Forward yield 1.83%
    • Payable Sept. 8; for shareholders of record Aug. 17; ex-div Aug. 13.
    | Jul. 28, 2015, 5:47 PM | 4 Comments
  • Mar. 4, 2015, 4:36 PM
    • Amgen (NASDAQ:AMGN) declares $0.79/share quarterly dividend, in line with previous.
    • Forward yield 1.99%
    • Payable June 5; for shareholders of record May 14; ex-div May 12.
    | Mar. 4, 2015, 4:36 PM
  • Dec. 18, 2014, 7:01 AM
    • Amgen (NASDAQ:AMGN) declares $0.79/share quarterly dividend, 29.5% increase from prior dividend of $0.61.
    • Forward yield 1.93%
    • Payable March 6; for shareholders of record Feb. 12; ex-div Feb. 10.
    | Dec. 18, 2014, 7:01 AM | 1 Comment
  • Oct. 17, 2014, 4:22 PM
    • Amgen Inc. (NASDAQ:AMGN) declares $0.61/share quarterly dividend, in line with previous.
    • Forward yield 1.83%
    • Payable Dec. 5; for shareholders of record Nov. 13; ex-div Nov. 11.
    | Oct. 17, 2014, 4:22 PM
  • Jul. 25, 2014, 4:03 PM
    • Amgen Inc. (NASDAQ:AMGN) declares $0.61/share quarterly dividend, in line with previous.
    • Forward yield 1.99%
    • Payable Sept. 5; for shareholders of record Aug. 14; ex-div Aug. 12.
    | Jul. 25, 2014, 4:03 PM
  • Mar. 11, 2014, 9:14 AM
    • Analysts Review (AMGN) declares $0.61/share quarterly dividend, in line with previous.
    • Forward yield 1.95%
    • Payable June 6; for shareholders of record May 15; ex-div May 13.
    | Mar. 11, 2014, 9:14 AM
  • Mar. 5, 2014, 5:38 PM
    • Amgen Inc. (AMGN) declares $0.61/share quarterly dividend, in line with previous.
    • Forward yield 1.93%
    • Payable June 6; for shareholders of record May 15; ex-div May 13.
    | Mar. 5, 2014, 5:38 PM
  • Dec. 13, 2013, 5:07 PM
    • Amgen Inc. (AMGN) declares $0.61/share quarterly dividend,29.8% increase from the prior dividend of $0.47
    • Forward yield 2.18%
    • Payable March 7; for shareholders of record Feb. 13; ex-div Feb. 11.
    | Dec. 13, 2013, 5:07 PM | 1 Comment
  • Oct. 16, 2013, 4:56 PM
    • Amgen Inc. (AMGN) declares $0.47/share quarterly dividend, in line with previous.
    • Forward yield 1.65%
    • Payable Dec. 6; for shareholders of record Nov. 14; ex-div Nov. 12.
    | Oct. 16, 2013, 4:56 PM
  • Jul. 26, 2013, 5:01 PM
    Amgen Inc. (AMGN) declares $0.47/share quarterly dividend, in line with previous. Forward yield 1.72%. For shareholders of record Aug. 16. Payable Sept. 6. Ex-div Aug. 14. (PR)
    | Jul. 26, 2013, 5:01 PM
  • Mar. 6, 2013, 5:27 PM
    Amgen, Inc. (AMGN) declares $0.47/share quarterly dividend, in line with previous. Forward yield 2.02%. For shareholders of record May 16. Payable June 07. Ex-div date May 14. (PR)
    | Mar. 6, 2013, 5:27 PM
  • Dec. 13, 2012, 5:22 PM
    Amgen (AMGN) declares $0.47/share quarterly dividend, 31% increase from prior dividend of $0.36. Forward yield 2.11%. For shareholders of record Feb. 13. Payable Mar. 07. Ex-div date Feb. 11. The board approved an increase in share repurchase program of $2.0B. (PR)
    | Dec. 13, 2012, 5:22 PM
Company Description
Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets... More
Sector: Healthcare
Industry: Biotechnology
Country: United States